Frontlight ResearchEarly access
Chronic kidney disease trials in Russia
4 of 5 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Active, not recruitingA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Rostov-on-Don, Saint Petersburg
- Age
- 18 years to 100 years
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - Phase 3TerminatedA Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
- Where
- Moscow, Saint Petersburg, Samara
- Age
- 0 years to 18 years
- People
- 56 worldwide
- Run by
- Amgen
See details and how to joinNCT03633708 - No phaseTaking peopleStudies on Adsorption International Learning Initiative Global
- Where
- Moscow
- Age
- 18 years and over
- People
- 60
- Run by
- Botkin Hospital
See details and how to joinNCT07123909 - No phaseTaking peopleEffect of Kidney Replacement Therapy with Polymethylmethacrylate Membranes on Pruritus-related Quality of Life in Patients Receiving Maintenance Haemodialysis
- Where
- Saint Petersburg
- Age
- 18 years and over
- People
- 62
- Run by
- Saint Petersburg State University, Russia
See details and how to joinNCT06671535